Seres Therapeutics Aktie
0,80
EUR
+0,03
EUR
+4,31
%
0,85
USD
+0,05
USD
+5,99
%
Werbung
Seres Therapeutics Aktie Analyse
| 22.10.18 | Seres Therapeutics Buy | Chardan Capital Markets | |
| 13.10.17 | Seres Therapeutics Outperform | Oppenheimer & Co. Inc. | |
| 04.08.17 | Seres Therapeutics Buy | H.C. Wainwright & Co. | |
| 01.02.17 | Seres Therapeutics Outperform | FBR & Co. | |
| 30.03.16 | Seres Therapeutics Outperform | FBR Capital | |
| 25.01.16 | Seres Therapeutics Buy | H.C. Wainwright & Co. | |
| 22.07.15 | Seres Therapeutics Buy | Canaccord Adams |
Werbung
Werbung